Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 312

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 312
---
 to which
the parties agreed to revise the Company Reference Value (as defined in the Merger Agreement) to adjust for financing proceeds received
by Profusa prior to the Business Combination, along with debt conversions and incentive shares to be issued. Additionally, the Amendment
(i) revised the definition of “Milestone Event III” such that the parties extended the period for Profusa to consummate
the APAC Joint Venture (as defined in the Merger Agreement) and receive the related funding from December 31, 2024 until December 31,
2025, and (ii) revised the definition of “Milestone Event IV” to change the earnout revenue target from $99,702,000
for the fiscal year ended December 31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December 31,
2026.

In relation to Milestone Event III: On
August 8, 2023, a new wholly owned subsidiary, Profusa Asia Pacific Pte. Ltd (“APAC”), was created and incorporated by
the Company under the laws of Singapore. Upon creation, the new entity was capitalized by the Company by payment of $1,000 for 1,000 Ordinary
Shares. As a result, at the time of incorporation, the entity became a wholly owned subsidiary of the Company. The entity was created
with the expectation of jointly conducting the business of developing, manufacturing and commercializing the Lumee Glucose and the Lumee
Oxygen products, currently under development by the Company, together with a third party. No business or activities will have been conducted
by the entity from the date of formation through and until the closing date of the proposed License Agreement and Shareholders Agreement
between the Company and Best Life Technology Ltd, an entity wholly owned and controlled by the Tasly Holding Group (“Tasly”)
which is a related party of the Company. In connection with and on or around the same date as the closing of the proposed Merger between
the Company and NorthView, the Company expects to sign and execute a License Agreement and Shareholders Agreement (the “APAC Joint
Venture”) setting forth the relative and other terms under which the development and business activities of the entity will be conducted.

<div align='center'>F-34

PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)</div>

Note